For Alzheimer's, a Fork in the Road
16:38 EDT 15 Jul 2012 | Wall Street Journal
Drug makers including Eli Lilly, Pfizer and J&J have spent hundreds of millions of dollars pursuing what could be the first treatments to address the underlying mechanism of Alzheimer's disease. Soon they'll know whether those bets have paid off.
Original Article: For Alzheimer's, a Fork in the Road
More From BioPortfolio on "For Alzheimer's, a Fork in the Road"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
